Healthspan Economy

ClinicalTrials.gov · NCT06459310 · Recruiting

Pilot Study on Evaluating the Geroprotective Effect of Metformin

Registry record

NCT06459310 on ClinicalTrials.gov. The registry's last update to this record was 21 March 2025.

Date checked: . This is the day the Atlas read the registry record; the registry may have changed since.

Verification record

5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked

  • Title as registered Pilot Study on Evaluating the Geroprotective Effect of Metformin Checked Source clinicaltrials.gov Brief title as registered. Checked
  • Sponsor Xuanwu Hospital, Beijing Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
  • Intervention Metformin Hydrochloride tablet; Placebo Checked Source clinicaltrials.gov Intervention names as registered. Checked
  • Primary outcome as registered Composite the efficacy of metformin in intervening aging Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
  • Status Recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2025-03-21. Checked

Check history: NCT06459310 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.

Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.

As registered

  • Sponsor: Xuanwu Hospital, Beijing
  • Phase: Phase 2
  • Status: Recruiting
  • Intervention: Metformin Hydrochloride tablet; Placebo
  • Primary outcome: Composite the efficacy of metformin in intervening aging
  • Countries: China
  • Start: 30 June 2024
  • Completion (estimated): 31 July 2028

Results

No results were posted on the registry on the date checked. The Atlas does not summarize findings.

A trial being registered is not evidence that the intervention works.